In patients undergoing percutaneous coronary intervention, per 1.0-SD increment in the METS-IR index was not significantly associated with major adverse cardiac and cerebrovascular events in the overall population (OR 1.05).
Cohort (n=1,461)
No
Do non-insulin-based insulin resistance indices (METS-IR, TG/HDL-C, TyG, TyG-BMI) predict major adverse cardiac and cerebrovascular events in patients undergoing percutaneous coronary intervention?
Non-insulin-based insulin resistance indices like METS-IR and TyG-BMI are associated with major adverse cardiac and cerebrovascular events in elderly and female patients undergoing PCI, but they do not improve the predictive power of established basic risk models.
Effect estimate: OR 1.05 (95% CI 0.89-1.24)
p-value: p=0.578
BACKGROUND: Insulin resistance (IR) has been confirmed that getting involved in the pathophysiological process of cardiovascular diseases (CVD). Recently, increasing evidence suggests metabolic score for insulin resistance (METS-IR), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, triglyceride and glucose (TyG) index, triglyceride glucose-body mass (TyG-BMI) index are simple and reliable surrogates for IR. However, their abilities in predicting cardiovascular outcomes in patients undergoing percutaneous coronary intervention (PCI) are not well explored. Therefore, this study aimed to investigate the association and evaluate the predictive performance of each index. METHODS: A total of 2533 consecutive participants undergoing PCI were included in this study, and the data from 1461 patients were used to determine the correlation of these non-insulin-based IR indices with major adverse cardiac and cerebrovascular events (MACCEs) via performing the multivariate logistic models and restricted cubic splines (RCS). RESULTS: During a median of 29.8 months follow-up, 195 cases of 1461 patients experienced incident MACCEs. In the overall population, both univariate and multivariate logistic regression analyses indicated no statistically significant connection between these IR indices and MACCEs. Subgroup analyses revealed significant interactions between age subgroups and TyG-BMI index, as well as METS-IR, and between sex subgroups and TyG index. In elderly patients, per 1.0-SD increment in TyG-BMI index and METS-IR had a significant association with MACCEs, with odds ratios (ORs) 95% confidence interval (CI) of 1.24 (1.02-1.50) and 1.27 (1.04-1.56), respectively (both P < 0.05). Moreover, in female patients, all the IR indices showed significant associations with MACCEs. Multivariable-adjusted RCS curves demonstrated a linear relationship between METS-IR and MACCEs in elderly and female patients, respectively. However, all the IR indices failed to enhance the predictive performance of the basic risk model for MACCEs. CONCLUSION: All the four IR indices showed a significant association with MACCEs in female individuals, whereas only TyG-BMI index and METS-IR showed associations in elderly patients. Although the inclusion of these IR indices did not improve the predictive power of basic risk model in either female or elderly patients, METS-IR appears to be the most promising index for secondary prevention of MACCEs and risk stratification in patients undergoing PCI.
Zhang et al. (Thu,) conducted a cohort in Coronary artery disease undergoing percutaneous coronary intervention (n=1,461). Non-insulin-based insulin resistance indices (METS-IR) was evaluated on Major adverse cardiac and cerebrovascular events (MACCEs) (OR 1.05, 95% CI 0.89-1.24, p=0.578). In patients undergoing percutaneous coronary intervention, per 1.0-SD increment in the METS-IR index was not significantly associated with major adverse cardiac and cerebrovascular events in the overall population (OR 1.05).